Ticker Details
Royalty Pharma plc
IPO Date:	June 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$25.69B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 1.42%
Avg Daily Range (30 D):	$0.94 | 1.68%
Avg Daily Range (90 D):	$0.74 | 1.45%

Institutional Daily Volume
Avg Daily Volume:	2.14M
Avg Daily Volume (30 D):	2.85M
Avg Daily Volume (90 D):	2.64M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	68

Institutional Trades
Total Institutional Trades:	10,264
Avg Institutional Trade:	$4.9M
Avg Institutional Trade (30 D):	$7.12M
Avg Institutional Trade (90 D):	$5.87M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$15.52M
Avg Closing Trade (30 D):	$52.05M
Avg Closing Trade (90 D):	$35.93M
Avg Closing Volume:	414.87K

News

Apr 21, 2026 @ 5:00 PM Royalty Pharma Launches Global Translational Prize... Source: Na

Apr 17, 2026 @ 12:30 PM Royalty Pharma Declares Second Quarter 2026 Divide... Source: Na

Apr 1, 2026 @ 10:00 AM Zymeworks Appoints Kristin Stafford as Chief Finan... Source: Na

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Mar 2, 2026 @ 12:00 PM Royalty Pharma Appoints Kenneth Sun as Senior Vice... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.91	$.67	$.5
Diluted EPS	$1.91	$.67	$.5
Revenue	$2.44B	$630.58M	$621.99M
Gross Profit
Net Income / Loss	$1.36B	$468.26M	$355.91M
Operating Income / Loss	$1.59B	$563.04M	$388.38M
Cost of Revenue
Net Cash Flow	$-501.33M	$-32.3M	$-320.25M
PE Ratio

Splits
Oct 15, 2010	1:4